Siddhartha Jaiswal
Hematology · 2009–2019
A researcher in the Science corpus: 7 papers; trusts 8 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Hematology — 66 citations into it
- Molecular Biology — 60 citations into it
- Genetics — 36 citations into it
- Cancer Research — 34 citations into it
- Oncology — 24 citations into it
- Pathology and Forensic Medicine — 12 citations into it
- Epidemiology — 9 citations into it
- Physiology — 9 citations into it
Whom Siddhartha Jaiswal trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Dirk Schübeler
- Iñigo Martincorena
- Claudio Franceschi
- C. Tomasetti
- R. Majeti
- Bert Vogelstein
- J. Campisi
- A. Wagers
- Po-Ru Loh
- Thomas A. Kunkel
Who trusts Siddhartha Jaiswal overall
Papers from Siddhartha Jaiswal's perspective
Ordered by how strongly the researchers Siddhartha Jaiswal trusts endorse each paper. Same corpus, a different order for every researcher.
- Recurrent Somatic TET2 Mutations in Normal Elderly Individuals With Clonal Hematopoiesis (Nature Genetics)
- Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome (New England Journal of Medicine)
- The hallmarks of cancer (RNA Biology)
- The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor (Nature)
- TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. (Cancer Cell)
- CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells (Cell)
- Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. (Cell Stem Cell)
- Integrin-associated protein (CD47) and its ligands. (Trends in Cell Biology)
- Stem cells, cancer, and cancer stem cells (Nature)
- Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. (New England Journal of Medicine)
Their papers
- CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells (2009) — 1,689 citations
- Clonal hematopoiesis in human aging and disease (2019) — 975 citations
- Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. (2015) — 1,824 citations
- Age-related clonal hematopoiesis associated with adverse outcomes. (2014) — 4,169 citations
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors (2012) — 1,535 citations
- Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47 (2010) — 737 citations
- CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. (2009) — 1,544 citations